Methods of ovarian suppression used in the UK

Breast

Volumn 11, Issue 1, 2002, Pages 23-29

  Featherstone, C J ^a   Harnett, A N ^a   Brunt, A M ^b   Johnson, L ^c  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN DERIVATIVE;

BREAST CANCER; CANCER LOCALIZATION; CLINICAL PRACTICE; CLINICAL STUDY; CONSULTATION; CONTROLLED STUDY; ECHOMAMMOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MEDICAL DECISION MAKING; OVULATION INHIBITION; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; UNITED KINGDOM;

EID: 0036166237     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2001.0356     Document Type: Review

References (21)

1. On the treatment of inoperable cases of carcinoma of the mamma - Suggestions for a new method of treatment with illustrative cases
2. Primary breast cancer: The effect of primary irradiation
3. Therapeutic castration in the treatment of advanced breast cancer
4. Adrenalectomy and oophorectomy in the treatment of advanced carcinoma of the breast
5. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy
6. Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: Results of a multicentric Italian study
7. Ovarian ablation in early breast cancer: Overview of the randomized trials
8. Multicentre randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic disease: An intergroup study
9. Ovarian ablation in breast cancer, 1896 to 1998: Milestones along hierarchy of evidence from case report to Cochrane review
10. Late effects of adjuvant oophorectomy and chemotherapy upon premenopausal breast cancer patients
11. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node positive breast cancer-an update of the Guy's/Manchester trial
12. Ovarian function and adjuvant chemotherapy for early breast cancer
13. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance
14. Endocrine effects of adjuvant chemotherapy and long term Tamoxifen on node-positive patients with breast cancer
15. Effect of prednisolone on hormone profiles during primary endocrine treatment of Advanced Breast Cancer
16. Ultrasound localization of the ovaries for radiation-induced ovarian ablation
17. Artificial radiation menopause: Where are the ovaries
18. Ovarian ablation failures by radiotherapy: A comparison of two dose schedules
19. Combined endocrine effects of LHRH agonist (Zoladex) and tamoxifen (Novaldex) therapy in premenopausal women with breast cancer
20. Luteinizing hormone-releasing hormone analogues in early breast cancer: Updated status of ongoing clinical trials